Tag: Patient Safety

Efficacy of metformin, ivermectin, fluvoxamine for COVID-19

Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…

Read More

By: Judy Mathias
August 31, 2022
Share

FDA: Class I recall of Intera 3000 Hepatic Artery Infusion Pump

Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…

Read More

By: Judy Mathias
August 31, 2022
Share

Moral distress in healthcare providers working in safety net practices during COVID-19

Editor's Note This study led by researchers at the University of North Carolina School of Medicine, Chapel Hill, finds that nearly 72% of healthcare providers in US safety net practices experienced either mild or intense levels of moral distress during the first year of COVID-19 because of issues with patient…

Read More

By: Judy Mathias
August 30, 2022
Share

Effect of aspirin vs enoxaparin on VTE after total hip, knee arthroplasty

Editor's Note This study (CRISTAL randomized trial) from Australia finds that aspirin compared with enoxaparin resulted in significantly higher rates of venous thromboembolism (VTE) after total hip or knee arthroplasty. This cluster-randomized, crossover trial included 9,711 patients in 31 hospitals in Australia—5,675 in the aspirin group and 4,036 in the…

Read More

By: Judy Mathias
August 29, 2022
Share

FDA: Class I recall of Medtronic’s HeartWare HVAD system batteries

Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…

Read More

By: Judy Mathias
August 29, 2022
Share

Regular physical activity linked to lower risk of COVID-19 infection, adverse outcomes

Editor's Note This meta-analysis led by researchers in Spain finds that regular physical activity is associated with a lower risk of COVID-19 infection, severity, and mortality. The analysis included 1,853,610 adults from multiple countries worldwide—54% were women, and the average age was 53. Compared with physically inactive individuals, those who…

Read More

By: Judy Mathias
August 24, 2022
Share

FDA: Hospira recalls another lot of Propofol

Editor's Note The Food and Drug Administration (FDA) on August 22 posted the Hospira Inc (a Pfizer company) recall of one lot of Propofol Injectable Emulsion (containing Benzyl alcohol), 100 mL single patient use glass fliptop vials, lot EA7470. The recall was initiated because of visible particulates observed in two…

Read More

By: Judy Mathias
August 23, 2022
Share

FDA: Class I recall of Medtronic Cobalt/Crome ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA) on August 19 identified the recall by Medtronic of its Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) as Class I, the most serious. The devices are being recalled because of reports of short circuit-protection…

Read More

By: Judy Mathias
August 22, 2022
Share

Unprofessional behavior improved with just a cup of coffee

What if unprofessional behavior in the OR could be managed through something as simple as an informal chat over a cup of coffee? This peer-to-peer approach advocated by Vanderbilt University School of Medicine led to the development of two well-established, scientifically validated programs designed to offset unprofessional behavior: the Patient…

Read More

By: Brita Belli
August 19, 2022
Share

Study: More than half unaware of Omicron infection status

Editor's Note This study led by researchers at Cedars-Sinai Medical Center, Los Angeles, finds that more than half of adults with recent Omicron infection analyzed were unaware of their infectious status. Of 210 adult employees or patients at Cedars-Sinai Medical Center with serological evidence of recent Omicron variant infection: 92…

Read More

By: Judy Mathias
August 18, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat